Riskpilot← Back to searchSign inGet full accessCENTERKLINIKKEN AS
ASActiveOrg 812812262Trondheimsvegen - Kløfta 65A, 2040 KløftaRental and operating of own or leased real estate · NACE 6820Est. 20130 employees
Revenue 2024
NOK 1,8M
+9% vs 2023
EBITDA margin
17.3%
+5% vs 2023
Equity ratio
86.5%
Financial strength
Net profit 2024
NOK 245K
+17% vs 2023
| Revenue | NOK 1,8M | +9% |
| EBITDA | NOK 315K | +5% |
| Net profit | NOK 245K | +17% |
| Total assets | NOK 719K | +63% |
| Equity | NOK 622K | +65% |
| Employees | 0 | — |
Legal name
CENTERKLINIKKEN AS
Org number
812812262
Legal form
Aksjeselskap
NACE code
6820 · Rental and operating of own or leased real estate
Founded
5. desember 2013
Share capital
NOK 100 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg. Daglig leder alene.
Company purpose
Selskapets formål er å drive utleie av lokale og drift av virksomhet innenfor fysioterapi, manuell terapi, osteopati og coaching med det som naturlig faller inn undet slik virksomhet og/eller ha interesser i annen virksomhet.
Address
Trondheimsvegen - Kløfta 65A, 2040 Kløfta
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 805 | 875 | 956 | 1 047 | 1 179 | 1 424 | 1 342 | 1 569 | 1 478 | 1 664 | 1 818 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −9 | −19 | −0 | −0 | −0 |
| EBITDA | 42 | 226 | 86 | −47 | 111 | 51 | 77 | 262 | 81 | 300 | 315 |
| Depreciation & amort. | −63 | −46 | −44 | −59 | −66 | −50 | −50 | −50 | −25 | −25 | −2 |
| EBIT | −21 | 181 | 42 | −106 | 45 | 1 | 27 | 211 | 56 | 275 | 313 |
| Net financials | −40 | −33 | −38 | −27 | −44 | −15 | −96 | −10 | 0 | 1 | −1 |
| Profit before tax | −61 | 148 | 4 | −133 | 1 | −14 | −69 | 201 | 56 | 275 | 312 |
| Tax | −14 | 41 | 3 | −27 | 6 | 15 | −15 | 45 | 19 | 66 | 67 |
| Net profit | −47 | 107 | 1 | −106 | −5 | −29 | −54 | 156 | 37 | 210 | 245 |
| Item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 576 | 591 | 582 | 506 | 529 | 410 | 271 | 232 | 215 | 442 | 719 |
| Equity | 53 | 161 | 162 | 55 | 51 | 22 | −26 | 130 | 167 | 377 | 622 |
| Long-term debt | 400 | 306 | 305 | 300 | 300 | 387 | 294 | 27 | 0 | 0 | 1 |
| Short-term debt | 123 | 124 | 116 | 151 | 179 | 1 | 2 | 75 | 48 | 65 | 96 |
| Total debt | 523 | 430 | 421 | 451 | 479 | 388 | 296 | 102 | 48 | 65 | 97 |
EBITDA margin
17.3%
This company
15.8%
Market median
+9% vs market
20142024
Equity ratio
86.5%
This company
38.2%
Market median
+126% vs market
20142024
Return on equity
39.4%
This company
18.4%
Market median
+114% vs market
20142024
Net profit margin
13.5%
This company
8.1%
Market median
+67% vs market
20142024
Asset turnover
2.53×
This company
1.12×
Market median
+126% vs market
20142024
Debt / equity
0.16×
This company
0.62×
Market median
+74% vs market
20142024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via Brønnøysundsregistrene · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via Brønnøysundsregistrene · Period 2014-01-01 – 2014-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
IC Chief Executive Officer | Chief Executive Officer | 2013 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2019 | — | — | |
| Board of Directors | 2019 | — | — | |
| Board of Directors | 2019 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Cn-Manuellterapi As | Company | 25.0% | 25.0% | 2022 |
Movebeyond As | Company | 25.0% | 25.0% | 2022 |
Dynamic Change As | Company | 25.0% | 25.0% | 2022 |
Ine C.Thorkildssen As | Company | 25.0% | 25.0% | 2022 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Ine C.Thorkildssen As
CENTERKLINIKKEN AS Board members of CENTERKLINIKKEN AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ine Charlotte Thorkildssen | Chief Executive Officer | 0 companies |
| Betina Vestergaard Thomsen | Chairman | 0 companies |
| Ingeborg Skyrud | Board of Directors | 0 companies |
| Christoph Tornes Nicolaysen | Board of Directors | 0 companies |